Add Yahoo as a preferred source to see more of our stories on Google. A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in ...

Mylan NV on Wednesday named Chairman Robert Coury to the role of executive chairman to help steer the drugmaker through the coronavirus pandemic and its delayed merger with Pfizer Inc's off-patent ...

(Reuters) - Mylan NV, which has come under fire for its drug pricing, said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment for $300 per two-pack, a more ...

Logo of Mylan Laboratories, a company primarily engaged in the commercialization of generic drugs is pictured in Merignac near Bordeaux BENGALURU (Reuters) - Drugmaker Mylan NV said on Wednesday it ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Shareholders will have to make travel arrangements, though ...

After dodging a $40 billion hostile takeover bid by Teva Pharmaceutical Industries Ltd. and forcing Teva to dump its former transactional lawyers at Kirkland & Ellis, it looks like Mylan NV is finally ...

Shares of Mylan NV (MYL) were down 1.13% to $31.43 in midday trading on Wednesday, Aug. 9, after the company reported second-quarter results and reduced its expected performance for the rest of the ...

(Reuters) - Mylan NV on Monday beat a clutch of drugmakers racing to get a biosimilar to Amgen Inc's blockbuster drug, Neulasta, to market, with U.S. health regulators approving its version of the ...

A new year brings a new deal for Mylan NV. After thwarted tie-ups last year with Teva Pharmaceutical Industries Ltd. and Perrigo Co. PLC, global generics giant Mylan said Wednesday that it will ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So what: According ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Occurs as the company deals not only with the COVID-19 ...